| Name | Title | Type |
|---|---|---|
| David Damond | Chief Financial Officer | Auditee |
| Sibi Thomas | Shareholder | Auditee |
| Edward Miller | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 360404 | 2024 | 2025-06-27 | Grant Thornton LLP | $16.39M |
| 302514 | 2023 | 2024-04-03 | Mayer Hoffman McCann CPAS | $9.96M |
| 73576 | 2022 | 2023-03-16 | Mayer Hoffman McCann CPAS | $13.85M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 360404 | 2024 | 2025-06-27 | 1144477 | 2024-005 | Material Weakness | - | L |
| 360404 | 2024 | 2025-06-27 | 1144476 | 2024-005 | Material Weakness | - | L |
| 360404 | 2024 | 2025-06-27 | 1144475 | 2024-005 | Material Weakness | - | L |
| 360404 | 2024 | 2025-06-27 | 1144474 | 2024-005 | Material Weakness | - | L |
| 360404 | 2024 | 2025-06-27 | 1144473 | 2024-004 | Significant Deficiency | - | B |
| 360404 | 2024 | 2025-06-27 | 1144472 | 2024-004 | Significant Deficiency | - | B |
| 360404 | 2024 | 2025-06-27 | 1144471 | 2024-004 | Significant Deficiency | - | B |
| 360404 | 2024 | 2025-06-27 | 1144470 | 2024-004 | Significant Deficiency | - | B |
| 360404 | 2024 | 2025-06-27 | 568035 | 2024-005 | Material Weakness | - | L |
| 360404 | 2024 | 2025-06-27 | 568034 | 2024-005 | Material Weakness | - | L |
| 360404 | 2024 | 2025-06-27 | 568033 | 2024-005 | Material Weakness | - | L |
| 360404 | 2024 | 2025-06-27 | 568032 | 2024-005 | Material Weakness | - | L |
| 360404 | 2024 | 2025-06-27 | 568031 | 2024-004 | Significant Deficiency | - | B |
| 360404 | 2024 | 2025-06-27 | 568030 | 2024-004 | Significant Deficiency | - | B |
| 360404 | 2024 | 2025-06-27 | 568029 | 2024-004 | Significant Deficiency | - | B |
| 360404 | 2024 | 2025-06-27 | 568028 | 2024-004 | Significant Deficiency | - | B |